Article
Envision Pharma Group
AI in Medical Affairs
Summary
In this episode, Tom Caravela and Patrina Pellett discuss insights from a recent AI in Medical Affairs conference. Tom highlights the lively atmosphere and key AI topics like efficiencies, patient outcomes, and use cases. The conversation covers AI's role in content development, training, predictive analytics, and its impact on medical affairs and the patient journey. They explore AI's potential in rare disease identification and insights analysis, emphasizing the human element and business efficiencies. Key takeaways include the importance of prompt engineering and custom GPTs.
AI in Medical Affairs, patient outcomes, predictive analytics, rare disease identification, prompt engineering
Related Topics
You May Also Like
Envision Pharma Group
Podcast
MSL Talk: Tom Caravela, Paul Ward
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Podcast
MSL Talk: Tom Caravela, Patrina Pellett
Fierce Pharma Engage 2025 - RECAP
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy